Amneal Pharmaceuticals, Inc. Class A Common Stock (NASDAQ: AMRX) last traded at $17.91, up 0.06% on the session. The quote above updates while this page is open; the figures below are drawn from Amneal Pharmaceuticals, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Amneal Pharmaceuticals, Inc. Class A Common Stock trades on NASDAQ under the ticker AMRX. Its market capitalisation is $5.72 billion.
Valuation measures for Amneal Pharmaceuticals, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.72B |
|---|---|
| P/E ratio | 37.31 |
| Price / sales | 1.83 |
| Price / book | 173.20 |
| Beta | 0.64 |
Trailing-twelve-month figures tagged in Amneal Pharmaceuticals, Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.12B |
|---|---|
| Net income (TTM) | $157.36M |
| EPS (TTM) | $0.480 |
| Gross margin | 39.32% |
| Operating margin | 14.56% |
| Return on equity | 476.51% |
| Cash | $127.64M |
Range and volume for AMRX over the past 52 weeks.
| 52-week high | $19.26 |
|---|---|
| 52-week low | $9.20 |
| Volume | 1.20M |
| Average volume | 2.02M |
| Previous close | $17.90 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.